[18F]APN-1607 PET in Subjects With AD Compared to HC

Clinical trial NCT05542953 · COMPLETED

Trial details

NCT number: NCT05542953
Sponsor: APRINOIA Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease Mild Cognitive Impairment Due to Alzheimer's Disease Healthy Volunteers

Start date: 2022-01-21
Primary completion: 2023-12-25
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.